Global Cyclic Heavy Menstrual Bleeding Market - Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Dec 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Cyclic Heavy Menstrual Bleeding Market By Type (Polymenorrhea, Oligomenorrhea, Metrorrhagia), By Treatment Type (Medication, Hormonal Therapy,  Surgery), By Route of Administration Type (Oral and Parenteral) By End Users (Hospitals, Homecare, Specialty Clinics, Others), By  Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), By Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa), Market Trends and Forecast to 2027

Market Analysis and Insights: Global Cyclic Heavy Menstrual Bleeding Market

Cyclic heavy menstrual bleeding market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the disease, growing awareness and development of newer therapies with minimum invasive nature are the factors responsible for the growth of this market

High prevalence rate drives the growth of cyclic heavy menstrual bleeding market. Growing cases of uterine fibroids and polyps boost up the cyclic heavy menstrual bleeding market growth. In addition, effective treatment cost and easy availability of treatment options plays a major role in growth of market in the above forecasted period. Furthermore, special designation from the regulatory authority is one of the significant factors which are expected to drive the market growth.

Cyclic heavy menstrual bleeding is also known as menorrhagia which defines as most common type of abnormal uterine bleeding. It is characterized by excessively prolonged and heavy menstrual bleeding at regular menstrual cycle intervals. It cause by several factors such as hormonal imbalance, dysfunction of the ovaries, uterine fibroids, polyps, adenomyosis and others.

Cyclic heavy menstrual bleeding market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Cyclic Heavy Menstrual Bleeding Market

Global Cyclic Heavy Menstrual Bleeding Market Scope and Market Size

The cyclic heavy menstrual bleeding market is segmented on the basis of types, treatment, route of administration, end-users and distribution channel.

  • Based on types, the cyclic heavy menstrual bleeding market is segmented into polymenorrhea, oligomenorrhea and metrorrhagia.
  • The treatment segment for cyclic heavy menstrual bleeding market includes medication, hormonal therapy and surgery. The medication segment is further categorized into Nonsteroidal Anti-inflammatory Drugs (NSAIDs), iron supplements, antifibrinolytics and others.  The hormonal therapy segment has been further bifurcated into oral progestogens, Gonadotropin-Releasing Hormone (GnRH) analogues and combined estrogens/progestogens. The surgery segment has also been further segmented into Dilation and Curettage (D&C), operative hysteroscopy, hysterectomy and others.
  • On the basis of route of administration, cyclic heavy menstrual bleeding market is segmented into oral and parenteral.
  • Based on end-user, the cyclic heavy menstrual bleeding market is segmented into hospitals, homecare, specialty clinics and others
  • Cyclic heavy menstrual bleeding market has also been segmented based on the distribution channel into hospital, pharmacy, online pharmacy, retail pharmacy and others.

Cyclic Heavy Menstrual Bleeding Market Country Level Analysis

The global cyclic heavy menstrual bleeding market is analyzed and market size information is provided by country, type, treatment, end- users and distribution channel as referenced above.

The countries covered in the cyclic heavy menstrual bleeding market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

North America was the leading revenue contributor to the cyclic heavy menstrual bleeding market due to growing incidence of uterine polyps or uterine cancer and potential players in the same geography while Asia- Pacific is expected to hold substantial growth due to the focus of various established market players to expand their presence in this particular region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Global cyclic heavy menstrual bleeding market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Cyclic Heavy Menstrual Bleeding Market Share Analysis

Global cyclic heavy menstrual bleeding market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to cyclic heavy menstrual bleeding market.

The major players covered in the cyclic heavy menstrual bleeding market are Clover Health Care Pharma, Inc., Ferring B.V., CSL Limited, AbbVie Inc, Fresenius Kabi, Mylan N.V., Akron Inc, Teva Pharmaceuticals Industries Ltd and among others.

Key Development:

In August 2019, AbbVie, Inc. submitted New Drug Application (NDA) to the FDA for elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist for the treatment of heavy menstrual bleeding associated with uterine fibroids. The elagolix has been previously approved for the treatment of moderate to severe pain associated with endometriosis.  If approved, it will significantly change treatment landscape and improves the quality of life for patient suffering from heavy menstrual bleeding associated with uterine fibroids in premenopausal women.

Customization Available : Global Cyclic Heavy Menstrual Bleeding Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions